Sinclair, Inc. has received an average recommendation of Hold from six research firms covering the stock, including one Sell, three Holds and two Buys. Analysts’ 12-month price target averages 19.00, with Guggenheim recently raising its target from 19.00 to 20.00 while assigning a Buy rating. Wall Street Zen upgraded Sinclair from Sell to Hold and Zacks Research moved the stock from Strong Sell to Hold, signaling a consensus view that the company’s current valuation and prospects warrant a wait-and-see approach.

Over the last three months insiders disposed of 50,637 shares, representing 41.90% insider ownership. Director Howard E. Friedman sold 14,713 shares in early January and EVP David B. Gibber sold 29,376 shares in December, each trimming their stakes by about 15%. On the institutional side, investors added to positions modestly: MIRAE ASSET GLOBAL ETFS boosted its holding by 4.3%, Ameritas Investment Partners by 26.2%, Kendall Capital Management by 3.8%, Geneos Wealth Management by 142.0% and JPMorgan Chase by 5.1%. Overall, institutional investors and hedge funds now own 41.71% of the company’s shares.

Sinclair has filed the full text of its exchange of letters with The E.W. Scripps Company, reiterating its willingness to engage on a combination that values Scripps at a premium exceeding 240% over its unadjusted share price, with a cash component alone reflecting a 32.7% premium. Scripps has declined to enter discussions, preferring to pursue its standalone plan. Sinclair’s board has stated that it will continue its strategic review of the Broadcast business and the separation of Ventures, with the goal of unlocking further value for shareholders.